European Mobtechs Dominate the Supply Market for Mobility-as-a-Service
7.3.2019 20:12:00 EET | Business Wire | Press release
A new study by PTOLEMUS Consulting Group finds that 12 of the top 17 B2B mobility platform providers in the world have their headquarters in Europe. These software suppliers have diverse backgrounds in road operation or technology but are all helped by a favourable environment and numerous city initiatives in Europe.
Frederic Bruneteau, PTOLEMUS’ Managing Director, stated: “While India just launched a vertically integrated national MaaS scheme, mobtechs are proposing a different model that relies on open software platforms for everybody to use. They are giving mobility operators an alternative to the inevitable dogfights between those who will eat (integrate) and those who will be eaten (integrated). This report sheds light on the specialist players that compete alongside government initiatives and giants such as Google and Uber”.
The Mobility Platform Suppliers handbook is the first to identify and appraise MaaS software suppliers and to clarify a very complex market. It will help cities, Public Transport Operators and mobility service providers choose the optimal model and deliver seamless mobility experiences.
The report maps the MaaS value chain and stakeholders. It also establishes the 6 levels of integration needed to deliver a complete MaaS solution. It includes an assessment of 17 key mobility platform suppliers, detailing their key clients, services, investors and case studies.
The handbook unpacks the MaaS ecosystem, stakeholders and architecture, covering:
- The necessary building blocks for a complete mobility platform
- The levels of MaaS integration
- The main players in each part of the MaaS value chain
- The top mobility platform providers
The study features:
- 150 pages of analysis of the complex ecosystem powering mobility-as-a-service,
- 17 MaaS platform suppliers assessed
- High level architecture of shared mobility platforms
- An independent ranking of the top technology providers in the MaaS market.
Download the abstract of the study here.
To discuss these questions directly with the authors, contact us at mobtech@ptolemus.com.
Suppliers analysed:
9 Transport Platform Providers:
- Bestmile
- INVERS
- Ecomobix
- Launch Mobility
- Omoove (Octo Telematics)
- Padam
- Ridecell
- Shotl
- Vulog
8 Mobility Platform Providers:
- A-to-Be (Brisa)
- Cubic
- Fluidtime (Kapsch)
- Moovel / Reach Now (BMW and Daimler)
- Moovit
- Optimile
- Siemens
- SkedGo
About PTOLEMUS Consulting Group
PTOLEMUS is the first strategy consulting & research firm entirely focused on connected & autonomous mobility. It assists leading public organisations, technology players, automotive OEMs, insurers and mobility service providers in defining & deploying their mobility strategies.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190307005576/en/
Contact information
Annie Reddaway, +447912571379, areddaway@ptolemus.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Watchmaker Genomics Licenses CRISPR-Cas9 Intellectual Property from Caribou Biosciences to Increase Throughput and Reduce Sequencing Cost per Sample17.2.2026 15:00:00 EET | Press release
Watchmaker Genomics, an innovator in high-performance solutions for next-generation sequencing (NGS), today announced a non-exclusive license with Caribou Biosciences, Inc., a leading clinical-stage CRISPR genome-editing biopharmaceutical company, for certain foundational CRISPR-Cas9 intellectual property for use in NGS library preparation. While CRISPR-Cas9 technologies are most commonly associated with their unique ability to find and cut for genome editing, Watchmaker is leveraging it in a fundamentally different way: as a programmable, stoichiometric binding tool to address one of the most persistent and under-optimized steps in NGS workflows – library normalization. “Normalization has quietly become a bottleneck as sequencing throughput has scaled,” said Brian Kudlow, CSO and Founderat Watchmaker Genomics. “This license gives us the freedom to rethink normalization from first principles, using CRISPR-Cas9 in a way that’s orthogonal to editing but highly aligned with modern sequenc
Esri and Pix4D Launch Real-Time Terrestrial Mapping Workflow17.2.2026 15:00:00 EET | Press release
Esri, the global leader in geographic information system (GIS) technology, has launched a terrestrial mapping workflow with Pix4D. A Switzerland-based photogrammetry software company, Pix4D specializes in mobile reality capture and site-digitization. The combined workflow allows field teams to capture and process asset data and manage it within ArcGIS, Esri’s geospatial platform. Field teams use the PIX4Dcatch app with real-time kinematics (RTK) devices to scan trenches and infrastructure. The generated high precision georeferenced records can now be published into Esri’s ArcGIS Online. Scans become 3D models and point clouds, viewable as a Scene Layer. Existing data can also be visualized in augmented reality for instant “as-designed” versus “as-built” verification before closing trenches. “We are focused on turning hidden infrastructure into functional data,” said Andrey Kleymenov, CEO of Pix4D. “By connecting PIX4Dcatch with a compatible RTK device to the Esri ecosystem, we are enab
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression17.2.2026 13:30:00 EET | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced today the successful achievement of the primary endpoint in the ongoing Phase 3 COMP006 trial, the second of two Phase 3 trials, which is evaluating two fixed doses of COMP360, a synthetic, proprietary formulation of psilocybin, for treatment-resistant depression (TRD). The primary endpoint was the difference in change from baseline in the Montgomery-Åsberg Depression Rating Scale (MADRS) scores between the 25 mg and 1 mg groups at Week 6. Two fixed doses – administered 3 weeks apart – of COMP360 25 mg versus 1 mg demonstrated a highly statistically significant reduction in symptom severity with a p-value of <0.001 and a clinically meaningful difference of -3.8 points in change at the primary endpoint. Across COMP005 and COMP006 to date, COMP360 is demonstrating a generally well-tolerated and safe profile, with treatment-emergent adverse events (
BeOne Medicines to Present at Upcoming Investor Conferences17.2.2026 13:00:00 EET | Press release
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Company will participate in fireside chats at four upcoming investor conferences: TD Cowen 46th Annual Health Care Conference on Monday, March 2, 2026 at 9:10 am ET; Leerink Global Healthcare Conference on Monday, March 9, 2026 at 11:20 am ET; Citizens Life Sciences Conference on Tuesday, March 10, 2026 at 9:35 am ET; and Barclays 28th Annual Global Healthcare Conference on Tuesday, March 10, 2026 at 3:00 pm ET Live webcasts of these events can be accessed from the investors section of the Company’s website at https://ir.beonemedicines.com. Archived replays will be available on the Company’s website. About BeOne Medicines BeOne Medicines is a global oncology company that is discovering and developing innovative treatments for cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel the
CTC Global Launches GridVista System and Strategic Partnership with Google Cloud and Tapestry to Transform Grid Intelligence17.2.2026 13:00:00 EET | Press release
CTC Global, the world’s leading developer and manufacturer of high-capacity advanced conductors, today announced the launch of the GridVista System. The GridVista System provides utilities with real-time, high-resolution data to optimize grid capacity, prevent outages, reduce wildfire risk, and lower operational costs. With the launch of the GridVista System, CTC is also announcing a deepening of its strategic partnership with Google Cloud and Tapestry—Alphabet’s moonshot for the electric grid. GridVista System’s unprecedented line awareness, paired with Google Cloud and Tapestry’s AI-powered tools, will transform line data into actionable intelligence for the grid. The GridVista System redefines transmission line intelligence by utilizing optical fibers embedded directly within CTC Global’s ACCC Conductor. Unlike legacy technology that relies on external sensors to estimate line conditions, GridVista provides direct visibility into strain, temperature, and vibration across the entire
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom